Cosmeceutical

The Gray Area

Cosmeceuticals occupy a gray zone between regulated drugs and cosmetics. While the term implies pharmaceutical-level efficacy, products marketed as cosmeceuticals are not subject to drug-level clinical testing or FDA approval. The concept was popularized by dermatologist Albert Kligman in the 1980s.

Product Category

Typical cosmeceuticals include products containing retinoids, vitamin C, alpha hydroxy acids, peptides, and growth factors at concentrations intended to produce measurable skin changes. They are often sold through dermatologists, medical spas, and specialty retailers rather than mass channels.

Regulatory Implications

The lack of a legal definition for ‘cosmeceutical’ creates both marketing opportunity and regulatory risk. Brands must carefully navigate claims — language suggesting drug-like effects can trigger regulatory scrutiny, while underplaying efficacy undermines the product’s positioning.

OSF Perspective

OSF sees cosmeceuticals as a category that bridges the gap between daily beauty routines and clinical treatments, empowering consumers who want science-backed results without medical procedures.

Related Terms

Active Ingredient  |  Retinoid  |  Clinical Trial (Cosmetics)  |  Dermatologist-Tested  |  Medical Aesthetics

Notable Brands

SkinCeuticals, Obagi, ZO Skin Health, iS Clinical, SkinMedica